Nearly 90% of infants globally received at least one dose of a diphtheria, tetanus and pertussis (DTP) vaccine in 2025, while around one-third of girls globally received at least one dose of Human Papillomavirus (HPV) vaccine, which protects against cervical cancer. This is according to the annual World Health Organization (WHO)-UNICEF Estimates of National Immunization […] Continue reading ->
As artificial intelligence drives rapid health innovations, global guardrails, equitable data, and local capacity are needed to ensure equitable progress. To address this, a landmark framework launched by three United Nations agencies lays out a strategic roadmap for innovators. Meanwhile, health leaders emphasise that lower-income regions must become co-creators of future innovations. New guidelines for […] Continue reading ->
HPV vaccines have transformed cervical cancer prevention, but the next generation of vaccines must better reflect regional disease patterns, including the HPV35 genotype prevalent in Africa.   The recent WHO Global Status Report on Cancer paints a sobering picture. Among the many challenges, human papillomavirus, or HPV, is one of the world’s most serious infectious causes of […] Continue reading ->
The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished.  In a […] Continue reading ->
Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading ->
Artificial intelligence promises huge efficiency gains for strained health systems, but algorithmic surveillance in long-term care systems also introduces profound ethical dilemmas. In response, the World Health Organization (WHO) has unveiled a comprehensive consultation draft on global long-term care standards to ensure digital innovation is balanced with fundamental human rights. Across the world, countries are […] Continue reading ->
Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading ->